Used primarily in pharmaceutical research, this compound serves as a key intermediate in the synthesis of various therapeutic agents. Its structure is particularly valuable in the development of central nervous system (CNS) drugs, including potential treatments for neurological disorders such as Alzheimer's disease and schizophrenia. The spirocyclic framework of the molecule allows for the creation of compounds with enhanced binding affinity and selectivity towards specific biological targets. Additionally, it is explored in the design of novel antidepressants and anxiolytics due to its ability to modulate neurotransmitter systems. Its application extends to the study of receptor interactions, aiding in the discovery of new drug candidates with improved efficacy and reduced side effects.